Nishit K Mukhopadhyay
Overview
Explore the profile of Nishit K Mukhopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kopanja D, Chand V, OBrien E, Mukhopadhyay N, Zappia M, Islam A, et al.
Cancer Res
. 2022 May;
82(13):2458-2471.
PMID: 35583996
Significance: This work provides new insights into how the interaction between FoxM1 and Rb facilitates the evolution of metastatic breast cancer cells by altering the transcriptome.
2.
Bommi P, Chand V, Mukhopadhyay N, Raychaudhuri P, Bagchi S
Oncogene
. 2019 Nov;
39(8):1784-1796.
PMID: 31740787
Cancers in the oral/head & neck region (HNSCC) are aggressive due to high incidence of recurrence and distant metastasis. One prominent feature of aggressive HNSCC is the presence of severely...
3.
Mukhopadhyay N, Chand V, Pandey A, Kopanja D, Carr J, Chen Y, et al.
Sci Rep
. 2018 Oct;
8(1):15850.
PMID: 30374061
A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.
4.
Mukhopadhyay N, Chand V, Pandey A, Kopanja D, Carr J, Chen Y, et al.
Sci Rep
. 2017 Apr;
7:46017.
PMID: 28387346
FoxM1b is a cell cycle-regulated transcription factor, whose over-expression is a marker for poor outcome in cancers. Its transcriptional activation function requires phosphorylation by Cdk1 or Cdk2 that primes FoxM1b...
5.
Li X, Chen Y, Josson S, Mukhopadhyay N, Kim J, Freeman M, et al.
PLoS One
. 2013 Aug;
8(8):e70987.
PMID: 23951060
MicroRNA (miRNA or miR) inhibition of oncogenic related pathways has been shown to be a promising therapeutic approach for cancer. Aberrant lipid and cholesterol metabolism is involved in prostate cancer...
6.
Cinar B, Collak F, Lopez D, Akgul S, Mukhopadhyay N, Kilicarslan M, et al.
Cancer Res
. 2011 Apr;
71(12):4303-13.
PMID: 21512132
The MST1 serine-threonine kinase, a component of the RASSF1-LATS tumor suppressor network, is involved in cell proliferation and apoptosis and has been implicated in cancer. However, the physiologic role of...
7.
Mukhopadhyay N, Kim J, Cinar B, Ramachandran A, Hager M, Di Vizio D, et al.
Cancer Res
. 2009 Mar;
69(6):2210-8.
PMID: 19258514
The regulation of androgen receptor (AR) expression in prostate cancer is still poorly understood. The activation of the epidermal growth factor receptor (EGFR) in prostate cancer cells was previously shown...
8.
Adam R, Yang W, Di Vizio D, Mukhopadhyay N, Steen H
BMC Cell Biol
. 2008 Jun;
9:30.
PMID: 18534013
Background: Cholesterol-rich membrane microdomains known as lipid rafts have been implicated in diverse physiologic processes including lipid transport and signal transduction. Lipid rafts were originally defined as detergent-resistant membranes (DRMs)...
9.
Cinar B, Mukhopadhyay N, Meng G, Freeman M
J Biol Chem
. 2007 Jul;
282(40):29584-93.
PMID: 17635910
The serine-threonine kinase, Akt1/protein kinase Balpha is an important mediator of growth, survival, and metabolic signaling. Recent studies have implicated cholesterol-rich, lipid raft microdomains in survival signals mediated by Akt1....
10.
Adam R, Mukhopadhyay N, Kim J, Di Vizio D, Cinar B, Boucher K, et al.
Cancer Res
. 2007 Jul;
67(13):6238-46.
PMID: 17616681
The serine-threonine kinase, Akt, has been linked to cholesterol-sensitive signaling mechanisms, suggesting a possible means whereby cholesterol might affect tumor cell growth and survival. However, it has not been shown...